Stay updated with breaking news from Lillian Eichner. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Researchers observed that combining two drugs, entinostat, and trametinib, can help reduce tumor size and number in mice with non-small cell lung cancer. Read more.
FDA-approved trametinib plus clinical trials-stage entinostate benefit mice with LKB1-mutated NSCLC.
There are two types of lung cancer.
Personalization of cancer treatments has long been a goal--finding the right drugs that work for a patient's specific tumour based on specific genetic and molecular patterns